These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31419648)

  • 1. Early clinical and EEG findings associated with the outcome in childhood absence epilepsy.
    Canafoglia L; Dettori MS; Duran D; Ragona F; Freri E; Casellato S; Granata T; Franceschetti S; Panzica F
    Epilepsy Behav; 2019 Sep; 98(Pt A):273-278. PubMed ID: 31419648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy.
    Wirrell E; Camfield C; Camfield P; Dooley J
    Epilepsia; 2001 Jun; 42(6):760-3. PubMed ID: 11422332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
    Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical trend toward improved long-term outcome in childhood absence epilepsy.
    Morse E; Giblin K; Chung MH; Dohle C; Berg AT; Blumenfeld H
    Epilepsy Res; 2019 May; 152():7-10. PubMed ID: 30856420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of background EEG activity in childhood absence epilepsy during valproate treatment: a standardized, low-resolution, brain electromagnetic tomography (sLORETA) study.
    Shin JH; Eom TH; Kim YH; Chung SY; Lee IG; Kim JM
    Neurol Sci; 2017 Jul; 38(7):1293-1298. PubMed ID: 28466144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Practical Guide to Treatment of Childhood Absence Epilepsy.
    Kessler SK; McGinnis E
    Paediatr Drugs; 2019 Feb; 21(1):15-24. PubMed ID: 30734897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG in childhood absence epilepsy.
    Yoshinaga H; Ohtsuka Y; Tamai K; Tamura I; Ito M; Ohmori I; Oka E
    Seizure; 2004 Jul; 13(5):296-302. PubMed ID: 15158699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset absence epilepsy aggravated by valproic acid: a video-EEG report.
    Belcastro V; Caraballo RH; Romeo A; Striano P
    Epileptic Disord; 2013 Dec; 15(4):440-3. PubMed ID: 24169439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
    Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence epilepsy in children: the role of EEG in monitoring response to treatment.
    Appleton RE; Beirne M
    Seizure; 1996 Jun; 5(2):147-8. PubMed ID: 8795131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy with myoclonic absences: Electroclinical characteristics in a distinctive pediatric epilepsy phenotype.
    Zanzmera P; Menon RN; Karkare K; Soni H; Jagtap S; Radhakrishnan A
    Epilepsy Behav; 2016 Nov; 64(Pt A):242-247. PubMed ID: 27770719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm follow-up of childhood epilepsy with absences. I. Epilepsy with absences at onset.
    Dieterich E; Baier WK; Doose H; Tuxhorn I; Fichsel H
    Neuropediatrics; 1985 Aug; 16(3):149-54. PubMed ID: 3930988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy?
    Schmitt B; Kovacevic-Preradovic T; Critelli H; Molinari L
    Neuropediatrics; 2007 Apr; 38(2):83-7. PubMed ID: 17712736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal current-source of spikes suggests initial treatment failure in childhood absence epilepsy.
    Yeom JS; Kim YS; Lee JH; Jung S; Kwon OY
    Seizure; 2015 Sep; 31():88-93. PubMed ID: 26362383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003032. PubMed ID: 16235312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset childhood absence epilepsy: is it a distinct entity?
    Farooque P; Goraya J; Valencia I; Carvalho KS; Hardison HH; Legido A; Khurana DS
    Epileptic Disord; 2011 Dec; 13(4):411-6. PubMed ID: 22258046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ictal connectivity in childhood absence epilepsy: Associations with outcome.
    Tenney JR; Kadis DS; Agler W; Rozhkov L; Altaye M; Xiang J; Vannest J; Glauser TA
    Epilepsia; 2018 May; 59(5):971-981. PubMed ID: 29633248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.